EU-funded project “MetaboliQs” coordinated by Fraunhofer IAF and NVision successfully concluded
Hyperpolarized nuclear magnetic resonance enables major medical advances in molecular diagnostics, for example for cardiovascular diseases or cancer therapy. Within the framework of the EU collaborative project “MetaboliQs”, seven partners coordinated by Fraunhofer IAF and NVision developed a microscopy method which, for the first time, enables the analysis of metabolic processes at the single cell level by means of diamond-based hyperpolarization. In addition, the consortium successfully demonstrated hyperpolarization using the PHIP method in application-oriented MRI experiments.